N. Duport, J. Silva, N. Villena, and I. , Cervico-uterine pathology: screening and surveillance of precancerous and cancerous lesions, Bull Epidémiol Hebd. mai, pp.1-43, 2014.

H. Autorité and D. Santé, État des lieux et recommandations pour le dépistage du cancer du col de l'utérus en France, HAS Guidel. juill, pp.1-235, 2010.

L. Markowitz, S. Hariri, C. Lin, E. Dunne, M. Steinau et al., Reduction in Human Papillomavirus (HPV) Prevalence Among Young Women Following HPV Vaccine Introduction in the United States, National Health and Nutrition Examination Surveys, 2003???2010, The Journal of Infectious Diseases, vol.208, issue.3, pp.385-93, 2003.
DOI : 10.1093/infdis/jit192

D. Mesher, K. Soldan, R. Howell-jones, K. Panwar, P. Manyenga et al., Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England, Vaccine, vol.32, issue.1, pp.26-32, 2013.
DOI : 10.1016/j.vaccine.2013.10.085

B. Lu, A. Kumar, X. Castellsagué, and A. Giuliano, Efficacy and Safety of Prophylactic Vaccines against Cervical HPV Infection and Diseases among Women: A Systematic Review & Meta-Analysis, BMC Infectious Diseases, vol.369, issue.9580, p.13, 2011.
DOI : 10.1016/S0140-6736(07)60946-5

J. Brotherton, M. Fridman, C. May, G. Chappell, A. Saville et al., Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study, The Lancet, vol.377, issue.9783, pp.2085-92, 2011.
DOI : 10.1016/S0140-6736(11)60551-5

S. Powell, S. Hariri, M. Steinau, H. Bauer, N. Bennett et al., Impact of human papillomavirus (HPV) vaccination on HPV 16/18-related prevalence in precancerous cervical lesions, Vaccine, vol.31, issue.1, pp.109-122, 2012.
DOI : 10.1016/j.vaccine.2012.10.092

H. Larson, C. Jarrett, E. Eckersberger, D. Smith, and P. Paterson, Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature, 2007???2012, Vaccine, vol.32, issue.19, pp.2150-2159, 2007.
DOI : 10.1016/j.vaccine.2014.01.081

P. Verger, L. Fressard, F. Collange, A. Gautier, C. Jestin et al., Vaccine Hesitancy Among General Practitioners and Its Determinants During Controversies: A National Cross-sectional Survey in France, EBioMedicine, vol.2, issue.8, pp.889-95, 2015.
DOI : 10.1016/j.ebiom.2015.06.018

F. Collange, L. Fressard, C. Pulcini, R. Sebbah, P. Peretti-watel et al., General practitioners??? attitudes and behaviors toward HPV vaccination: A French national survey, Vaccine, vol.34, issue.6, pp.762-770, 2016.
DOI : 10.1016/j.vaccine.2015.12.054

J. Haesebaert, D. Lutringer-magnin, J. Kalecinski, G. Barone, A. Jacquard et al., Disparities of Perceptions and Practices Related to Cervical Cancer Prevention and the Acceptability of HPV Vaccination According to Educational Level in a French Cross-Sectional Survey of 18???65 Years Old Women, PLoS ONE, vol.117, issue.10, p.109320, 2014.
DOI : 10.1371/journal.pone.0109320.s001

F. Binder-foucard, A. Belot, P. Delafosse, L. Remontet, A. Woronoff et al., [National estimate of the incidence and mortality from cancer in France between 1980 and 2012. A study based on Francim network of cancer registries -Part 1 ? Solid Tumors], 2013.

N. Duport, . Heard, . Isabelle, and S. Barré, Le cancer du col de l'utérus : état des connaissances en 2014, Bull Epidémiol Hebd, 2014.

N. Duport, D. Serra, H. Goulard, and J. Bloch, Quels facteurs influencent la pratique du dépistage des cancers féminins en France ? Rev DÉpidémiologie Santé Publique, oct, vol.56, issue.5, pp.303-316, 2008.

N. Duport, Dépistage organisé du cancer du col de l'utérus -Evaluation épidémiologique des quatre départements « pilotes

. Comité-de-pilotage-de-l-'inca, Plan cancer 2014-2019 [Internet]. INCA; 2014 févr 20, European Medicines Agency. Cervarix, INN-Human Papillomavirus Vaccine [Types 16

. European-medicines-agency and . Gardasil, INN-Human Papillomavirus Vaccine Agence Européenne des Médicaments, 2006.

S. Mahmud, E. Kliewer, P. Lambert, S. Bozat-emre, and A. Demers, Effectiveness of the Quadrivalent Human Papillomavirus Vaccine Against Cervical Dysplasia in Manitoba, Canada, Journal of Clinical Oncology, vol.32, issue.5, pp.438-481, 2014.
DOI : 10.1200/JCO.2013.52.4645

C. Chao, N. Klein, C. Velicer, L. Sy, J. Slezak et al., Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine, Journal of Internal Medicine, vol.302, issue.2, pp.193-203, 2012.
DOI : 10.1001/jama.2009.1201

L. Arnheim-dahlström, B. Pasternak, H. Svanström, P. Sparén, and A. Hviid, Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study, BMJ, vol.347, issue.oct09 4, p.5906, 2013.
DOI : 10.1136/bmj.f5906

. France-), P. Guilbert, and A. Gautier, Institut national de prévention et d'éducation pour la santé Baromètre santé 2005: premiers résultats. Saint-Denis: Éd. INPES, 2006.

E. Dubé, C. Laberge, M. Guay, P. Bramadat, R. Roy et al., Vaccine hesitancy: An overview. Hum Vaccines Immunother, pp.1763-73, 2013.

J. Menard and . Benfluorex, Benfluorex: Analysis of a drug-related public health crisis, Diabetes & Metabolism, vol.37, issue.3, pp.169-75, 2011.
DOI : 10.1016/j.diabet.2011.04.001

L. Cazi and E. , Des experts font le lien entre Gardasil et sclérose en plaques. Le Monde.fr, 2013.

D. Holman, V. Benard, K. Roland, M. Watson, N. Liddon et al., Barriers to Human Papillomavirus Vaccination Among US Adolescents, JAMA Pediatrics, vol.168, issue.1, pp.76-82, 2014.
DOI : 10.1001/jamapediatrics.2013.2752

A. Baudoin, L. Sabiani, F. Oundjian, E. Tabouret, A. Agostini et al., Vaccination anti-HPV??: ??valuation de la couverture vaccinale et des facteurs qui l???influencent chez les lyc??ennes et ??tudiantes de la r??gion PACA, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.44, issue.2, pp.126-161, 2015.
DOI : 10.1016/j.jgyn.2014.02.005

D. Lutringer-magnin, C. Cropet, G. Barone, G. Canat, J. Kalecinski et al., HPV vaccination among French girls and women aged 14???23 years and the relationship with their mothers??? uptake of Pap smear screening: A study in general practice, Vaccine, vol.31, issue.45, pp.5243-5252, 2013.
DOI : 10.1016/j.vaccine.2013.08.068

C. Lions, C. Pulcini, and P. Verger, Papillomavirus vaccine coverage and its determinants in South-Eastern France, M??decine et Maladies Infectieuses, vol.43, issue.5, pp.195-201, 2013.
DOI : 10.1016/j.medmal.2013.03.003

L. Sabiani, A. Bremond, I. Mortier, M. Lecuyer, L. Boubli et al., ??valuation de la couverture vaccinale du vaccin anti-hpv??: r??sultats d???une enqu??te aupr??s des lyc??ennes et ??tudiantes de la r??gion PACA, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.41, issue.2, pp.136-180, 2012.
DOI : 10.1016/j.jgyn.2011.10.001

O. Ganry, A. Bernin-mereau, M. Gignon, J. Merlin-brochard, and J. Schmit, Human papillomavirus vaccines in Picardy, France: Coverage and correlation with socioeconomic factors, Revue d'??pid??miologie et de Sant?? Publique, vol.61, issue.5, pp.447-54, 2013.
DOI : 10.1016/j.respe.2013.04.005

A. Bertaut, P. Chavanet, S. Aho, K. Astruc, S. Douvier et al., HPV vaccination coverage in French girls attending middle and high schools: a declarative cross sectional study in the department of C??te d???Or, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.170, issue.2
DOI : 10.1016/j.ejogrb.2013.07.028

C. Grondin, S. Duron, F. Robin, C. Verret, and P. Imbert, Adolescents' knowledge and behavior on sexuality, infectious transmitted diseases, and human papillomavirus vaccination: results of a survey in a French high school]. Arch Pédiatrie Organe Off Sociéte Fr Pédiatrie, août, vol.20, issue.8, pp.845-52, 2013.

M. Hendry, R. Lewis, A. Clements, S. Damery, and C. Wilkinson, ???HPV? Never heard of it!???: A systematic review of girls??? and parents??? information needs, views and preferences about human papillomavirus vaccination, Vaccine, vol.31, issue.45, pp.5152-67, 2013.
DOI : 10.1016/j.vaccine.2013.08.091

T. Mullins, A. Griffioen, S. Glynn, G. Zimet, S. Rosenthal et al., Human papillomavirus vaccine communication: Perspectives of 11???12 year-old girls, mothers, and clinicians, Vaccine, vol.31, issue.42, pp.4894-901, 2013.
DOI : 10.1016/j.vaccine.2013.07.033

L. Rambout, M. Tashkandi, L. Hopkins, and A. Tricco, Self-reported barriers and facilitators to preventive human papillomavirus vaccination among adolescent girls and young women: A systematic review, Preventive Medicine, vol.58
DOI : 10.1016/j.ypmed.2013.10.009

D. Phan, Q. Pham, M. Strobel, D. Tran, T. Tran et al., Acceptabilit?? de la vaccination contre les papillomavirus humains (HPV) par les p??diatres, les m??res et les jeunes femmes ?? H?? Chi Minh Ville, Vietnam, Revue d'??pid??miologie et de Sant?? Publique, vol.60, issue.6, pp.437-483, 2012.
DOI : 10.1016/j.respe.2012.03.010

B. Hansen, S. Campbell, E. Burger, and M. Nygård, Correlates of HPV vaccine uptake in school-based routine vaccination of preadolescent girls in Norway: A register-based study of 90,000 girls and their parents, Preventive Medicine, vol.77, pp.4-10, 2015.
DOI : 10.1016/j.ypmed.2015.04.024

C. Giambi, D. Ancona, F. , D. Manso, M. et al., Exploring reasons for non-vaccination against human papillomavirus in Italy, BMC Infect Dis, 2014.

C. Chabbert, La vaccination contre le HPV : étude en cabinet de médecine générale des facteurs associés à la décision des parents, 2015.

L. Gougenheim-fretin and M. Salembier, Reticences vis-a-vis du vaccin contre le HPV et solutions envisagées à partir d'une étude qualitative réalisée autprès de médecins traitants et de parents d'adolescentes, 2014.

L. Amessi, Connaissances sur les infections génitales à HPV et couverture vaccinale HPV des élèves d'un collège à Paris, 2016.

M. Kokotek, I. Genevois, P. Bourdeau, A. Niakate, and S. Quelet, Enquête d'acceptabilité par les mères de la vaccination HPV, 2013.

D. Antona, L. Fonteneau, D. Lévy-bruhl, N. Guignon, D. Peretti et al., Couverture vaccinale des enfants et des adolescents en France: résultats des enquêtes menées en milieu scolaire, Bull Epidemiol Hebd, vol.6, pp.45-54, 2001.

L. Mortensen, G. Adam, M. Idtaleb, and L. , Parental attitudes towards male human papillomavirus vaccination: a pan-European cross-sectional survey, BMC Public Health, vol.117, issue.1, p.624, 2015.
DOI : 10.1016/j.ypmed.2013.05.013

H. Partouche, O. Benainous, J. Barthe, J. Pierret, L. Rigal et al., A survey about determinants of 2009 pandemic influenza A(H1N1) vaccination among French general practionners patients. Motivac study], Rev Prat. déc, vol.61, issue.10, pp.1411-1418, 2011.

H. Partouche, M. Scius, C. Elie, and L. Rigal, Vaccination des nourrissons contre l???h??patite B??: connaissances, opinions et pratiques des m??decins g??n??ralistes de l???Est parisien en 2009, Archives de P??diatrie, vol.19, issue.2, pp.111-118, 2009.
DOI : 10.1016/j.arcped.2011.11.010

S. Oui, par quelle(s) source(s) d'information ?

S. Oui, par quelle(s) source(s) d'information ?